Pictet Asset Management (Switzerland)’s Editas Medicine EDIT Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$13.3M	Buy	1,613,141 +556,168	+53%	+$4.85M	0.02%	564
2023 Q1	$7.66M	Buy	1,056,973 +808,302	+325%	+$7.19M	0.01%	682
2022 Q4	$2.21M	Buy	248,671 +66,485	+36%	+$730K	﹤0.01%	914
2022 Q3	$2.23M	Buy	182,186 +49,782	+38%	+$776K	﹤0.01%	906
2022 Q2	$1.57M	Buy	132,404 +22,835	+21%	+$306K	﹤0.01%	981
2022 Q1	$2.08M	Buy	109,569 +10,058	+10%	+$187K	﹤0.01%	957
2021 Q4	$2.64M	Hold	99,511	–	–	﹤0.01%	961
2021 Q3	$4.09M	Buy	+99,511	New	+$5.45M	﹤0.01%	882

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s EDIT Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Editas Medicine (EDIT) stake by 53% in Q2 2023, buying an estimated $4.85M and bringing the position to 1,613,141 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #564.

Pictet Asset Management (Switzerland) first reported a position in EDIT in Q3 2021 and has held it in 8 quarters since. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,613,141 shares of Editas Medicine worth $13.3M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 556,168 Editas Medicine shares in Q2 2023, an estimated $4.85M.
Editas Medicine made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #564 holding.
Pictet Asset Management (Switzerland) first reported a position in Editas Medicine in Q3 2021 and has held it in 8 quarters since.
238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.